Suchergebnisse - "Yang, Jiao"

PubPharm (16)

1

Tongguanteng injection reverses paclitaxel resistance via upregulation of TAB1 expression in ovarian cancer in vitro and in vivo

enthalten in: Journal of ethnopharmacology | 2023

von Kong, Q. | Yang, J. | Li, D. | +11

2

RIP1 promotes proliferation through G2/M checkpoint progression and mediates cisplatin-induced apoptosis and necroptosis in human ovarian cancer cells

enthalten in: Acta pharmacologica Sinica | 2020

von Zheng, X. | Yang, J. | Wang, Y. | +8

3

Xiao-Ai-Ping Injection Enhances Effect of Paclitaxel to Suppress Breast Cancer Proliferation and Metastasis via Activating Transcription Factor 3

enthalten in: Integrative cancer therapies | 2020

von Chen, J. | Zhang, X. | Xiao, X. | +6

4

Tumor vasculature remolding by thalidomide increases delivery and efficacy of cisplatin

enthalten in: Journal of experimental & clinical cancer research : CR | 2019

von Shen, Y. | Li, S. | Wang, X. | +7

5

Identification of 5-(2,3-Dihydro-1 H-indol-5-yl)-7 H-pyrrolo[2,3- d]pyrimidin-4-amine Derivatives as a New Class of Receptor-Interacting Protein Kinase 1 (RIPK1) Inhibitors, Which Showed Potent Activity in a Tumor Metastasis Model

enthalten in: Journal of medicinal chemistry | 2018

von Li, Y. | Xiong, Y. | Zhang, G. | +13

ErratumIn: J Med Chem. 2019 Mar 28;62(6):3169. - PMID 30843694

6

Structural optimization and structure-activity relationship studies of N-phenyl-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-4-amine derivatives as a new class of inhibitors of RET and its drug resistance mutants

enthalten in: European journal of medicinal chemistry | 2018

von Yang, J. | Chen, K. | Zhang, G. | +14

7

Preclinical pharmacodynamic evaluation of drug candidate SKLB-178 in the treatment of non-small cell lung cancer

enthalten in: Oncotarget | 2017

von Zhong, L. | Yang, J. | Cao, Z. | +4

8

From Lead to Drug Candidate : Optimization of 3-(Phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Derivatives as Agents for the Treatment of Triple Negative Breast Cancer

enthalten in: Journal of medicinal chemistry | 2016

von Zhang, C. | Chen, K. | Jiao, Y. | +15

9

Biological Response Modifier in Cancer Immunotherapy

enthalten in: Advances in experimental medicine and biology | 2016

von Liu, R. | Luo, F. | Liu, X. | +9

10

Design, Synthesis, and Structure-Activity Relationship Studies of 3-(Phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Derivatives as a New Class of Src Inhibitors with Potent Activities in Models of Triple Negative Breast Cancer

enthalten in: Journal of medicinal chemistry | 2015

von Zhang, C. | Zheng, M. | Li, Y. | +15